{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:11:45Z","timestamp":1778069505142,"version":"3.51.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiogenic shock (CS) is a life-threatening syndrome characterized by systemic tissue hypoperfusion due to inadequate cardiac output. Despite advances in cardiovascular care, mortality remains high, particularly during the first hours and within the first month after onset, underscoring the need for early recognition and tailored therapeutic strategies. The marked heterogeneity of CS has prompted the development of phenotyping approaches encompassing clinical, haemodynamic, aetiological, and emo-metabolic dimensions. Clinically, patients may present as cold and congested, cold and dry, warm and congested, or warm and dry. From an aetiological perspective, CS may be ischaemic, related to de novo heart failure, acute decompensation of chronic heart failure, secondary, or mixed. Mixed shock\u2014characterized by the coexistence of pump failure and inappropriate systemic vasodilation\u2014is associated with higher mortality and rapid clinical deterioration. Advanced phenotyping strategies, including machine learning-based approaches, have identified additional CS subgroups with distinct prognostic profiles and therapeutic requirements. The Society for Cardiovascular Angiography and Interventions classification provides a practical framework for severity stratification and longitudinal monitoring, emphasizing the importance of frequent reassessment, particularly in early-stage patients at risk of rapid progression. Management of CS integrates pharmacological therapy\u2014including inotropes and vasopressors\u2014with mechanical circulatory support, tailored to the patient\u2019s phenotype and haemodynamic profile. Optimal care of cardiogenic shock relies on accurate phenotyping, dynamic risk assessment, and personalized therapeutic strategies to improve outcomes while minimizing complications.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suag045","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:41:30Z","timestamp":1771936890000},"page":"v128-v134","source":"Crossref","is-referenced-by-count":0,"title":["Cardiogenic shock is not a single entity: therapeutic implications"],"prefix":"10.1093","volume":"28","author":[{"given":"Marco","family":"Marini","sequence":"first","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Coraducci","sequence":"additional","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilda","family":"Shkoza","sequence":"additional","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Manfredi","sequence":"additional","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Belfioretti","sequence":"additional","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Angelini","sequence":"additional","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Pongetti","sequence":"additional","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Vittoria","family":"Matassini","sequence":"additional","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Battistoni","sequence":"additional","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Francioni","sequence":"additional","affiliation":[{"name":"Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche , Via Conca 71 60126 Torrette Ancona (AN) ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2026050607122171800_suag045-B1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock \u2013 a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"European J of Heart Fail"},{"key":"2026050607122171800_suag045-B2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcin.2015.10.039","article-title":"Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction","volume":"9","author":"Wayangankar","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2026050607122171800_suag045-B3","doi-asserted-by":"crossref","first-page":"i78","DOI":"10.1093\/eurheartjsupp\/suae023","article-title":"The golden hour in shock management: do a lot, do it quickly","volume":"26","author":"Marini","year":"2024","journal-title":"Eur Heart J Suppl"},{"key":"2026050607122171800_suag045-B4","doi-asserted-by":"crossref","first-page":"e005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618","article-title":"Epidemiology of shock in contemporary cardiac intensive care units: data from the critical care cardiology trials network registry","volume":"12","author":"Berg","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026050607122171800_suag045-B5","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"Van Diepen","year":"2017","journal-title":"Circulation"},{"key":"2026050607122171800_suag045-B6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.123.064527","article-title":"Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: scientific expert panel from the Shock Academic Research Consortium (SHARC)","volume":"148","author":"Waksman","year":"2023","journal-title":"Circulation"},{"key":"2026050607122171800_suag045-B7","doi-asserted-by":"crossref","first-page":"e011404","DOI":"10.1161\/CIRCHEARTFAILURE.123.011404","article-title":"Mixed shock complicating cardiogenic shock: frequency, predictors, and clinical outcomes","volume":"17","author":"Baldetti","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026050607122171800_suag045-B8","doi-asserted-by":"crossref","first-page":"e020085","DOI":"10.1161\/JAHA.120.020085","article-title":"Phenotyping cardiogenic shock","volume":"10","author":"Zweck","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026050607122171800_suag045-B9","doi-asserted-by":"crossref","first-page":"102257","DOI":"10.1016\/j.jacadv.2025.102257","article-title":"Identifying cardiogenic shock sub-phenotypes with machine learning: a multicenter study combining clinical and echocardiographic data","volume":"4","author":"Ghionzoli","year":"2025","journal-title":"JACC Adv"},{"key":"2026050607122171800_suag045-B10","first-page":"29","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026050607122171800_suag045-B11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2022.04.049","article-title":"Criteria for defining stages of cardiogenic shock severity","volume":"80","author":"Kapur","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026050607122171800_suag045-B12","first-page":"646","article-title":"Comprehensive non-invasive haemodynamic assessment in acute decompensated heart failure-related cardiogenic shock: a step towards echodynamics","volume":"13","author":"Frea","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026050607122171800_suag045-B13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ejhf.1436","article-title":"The role of ventricular\u2013arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology working group on aorta & peripheral vascular diseases, European association of cardiovascular imaging, and heart failure association","volume":"21","author":"Ikonomidis","year":"2019","journal-title":"European J of Heart Fail"},{"key":"2026050607122171800_suag045-B14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026050607122171800_suag045-B15","doi-asserted-by":"crossref","first-page":"e029787","DOI":"10.1161\/JAHA.123.029787","article-title":"State of shock: contemporary vasopressor and inotrope use in cardiogenic shock","volume":"12","author":"Bloom","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026050607122171800_suag045-B16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with Dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew","year":"2021","journal-title":"N Engl J Med"},{"key":"2026050607122171800_suag045-B17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with Dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"2026050607122171800_suag045-B18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ejhf.1145","article-title":"Efficacy and safety of intermittent intravenous outpatient administration of Levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial","volume":"20","author":"Com\u00edn-Colet","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026050607122171800_suag045-B19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"2026050607122171800_suag045-B20","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2025.03.003","article-title":"Early intra-aortic balloon support for heart failure-related cardiogenic shock","volume":"85","author":"Morici","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026050607122171800_suag045-B21","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"M\u00f8ller","year":"2024","journal-title":"N Engl J Med"},{"key":"2026050607122171800_suag045-B22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamacardio.2024.4197","article-title":"Microaxial flow pump hemodynamic and metabolic effects in infarct-related cardiogenic shock: a substudy of the DanGer shock randomized clinical trial","volume":"10","author":"Udesen","year":"2025","journal-title":"JAMA Cardiol"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/advance-article-pdf\/doi\/10.1093\/eurheartjsupp\/suag045\/67302870\/suag045.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/28\/Supplement_5\/v128\/67302870\/suag045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/28\/Supplement_5\/v128\/67302870\/suag045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:12:29Z","timestamp":1778065949000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/28\/Supplement_5\/v128\/8514533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":22,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2026,3,11]]},"published-print":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suag045","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,3,11]]}}}